CS207656B2 - Method of preparation of 2-oxo-3-acylamino-4-mercap-toazetidins - Google Patents
Method of preparation of 2-oxo-3-acylamino-4-mercap-toazetidins Download PDFInfo
- Publication number
- CS207656B2 CS207656B2 CS78971A CS97178A CS207656B2 CS 207656 B2 CS207656 B2 CS 207656B2 CS 78971 A CS78971 A CS 78971A CS 97178 A CS97178 A CS 97178A CS 207656 B2 CS207656 B2 CS 207656B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- acid
- alpha
- oxo
- thia
- hept
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 11
- 238000000034 method Methods 0.000 title claims description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 33
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 27
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 20
- -1 dimethylamino, 1-piperidinyl Chemical group 0.000 claims description 19
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000002769 thiazolinyl group Chemical group 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 238000010494 dissociation reaction Methods 0.000 claims description 2
- 230000005593 dissociations Effects 0.000 claims description 2
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 claims description 2
- 229960002523 mercuric chloride Drugs 0.000 claims description 2
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 claims description 2
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000005322 morpholin-1-yl group Chemical group 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 10
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 4
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical group OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- VCQHRSXINXLUDJ-UHFFFAOYSA-N 3,6-dimethyl-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-7-one Chemical compound S1C(C)=NC2C(=O)N(C)C21 VCQHRSXINXLUDJ-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- 125000004797 2,2,2-trichloroethoxy group Chemical group ClC(CO*)(Cl)Cl 0.000 description 1
- DIOSIZZBBKQLDC-UHFFFAOYSA-N 2-(3-formamido-2-oxo-4-sulfanylazetidin-1-yl)-3-methylbut-2-enoic acid Chemical compound CC(C)=C(C(O)=O)N1C(S)C(NC=O)C1=O DIOSIZZBBKQLDC-UHFFFAOYSA-N 0.000 description 1
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 description 1
- JUSXLWAFYVKNLT-UHFFFAOYSA-N 2-bromobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1Br JUSXLWAFYVKNLT-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- AOJBXSXDOLCYGD-UHFFFAOYSA-N 3-(phenoxymethyl)-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-7-one Chemical compound N=1C2C(=O)NC2SC=1COC1=CC=CC=C1 AOJBXSXDOLCYGD-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- VVOJXGOSFVWKBM-UHFFFAOYSA-N 3-methyl-2-(7-oxo-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)but-2-enoic acid Chemical compound S1C=NC2C(=O)N(C(=C(C)C)C(O)=O)C21 VVOJXGOSFVWKBM-UHFFFAOYSA-N 0.000 description 1
- ROKVMEFCSYPZBP-UHFFFAOYSA-N 4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-7-one Chemical class S1C=NC2C(=O)NC21 ROKVMEFCSYPZBP-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- 101100334117 Caenorhabditis elegans fah-1 gene Proteins 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- RYPQDRRDISLTAR-UHFFFAOYSA-N N-(1-acetyl-2-oxoazetidin-3-yl)-2-(4-sulfanylthiophen-3-yl)acetamide Chemical compound O=C1N(C(=O)C)CC1NC(=O)CC1=CSC=C1S RYPQDRRDISLTAR-UHFFFAOYSA-N 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- AVMNFQHJOOYCAP-UHFFFAOYSA-N acetic acid;propanoic acid Chemical compound CC(O)=O.CCC(O)=O AVMNFQHJOOYCAP-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000003978 alpha-halocarboxylic acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical group O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 1
- BWWVAYHQAKOPEK-UHFFFAOYSA-N benzenesulfonic acid;phenylmethanesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1.OS(=O)(=O)CC1=CC=CC=C1 BWWVAYHQAKOPEK-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- BBFMEMARFVCRCO-UHFFFAOYSA-N ethyl 2-[3-[(2-chloro-2-phenylacetyl)amino]-2-oxo-4-sulfanylazetidin-1-yl]-2-oxoacetate Chemical compound O=C1N(C(=O)C(=O)OCC)C(S)C1NC(=O)C(Cl)C1=CC=CC=C1 BBFMEMARFVCRCO-UHFFFAOYSA-N 0.000 description 1
- HDCDLRXOWXHIHY-UHFFFAOYSA-N ethyl 2-[5-(chloromethyl)-6-oxo-3-phenyl-2-thia-4,7-diazabicyclo[3.2.0]hept-3-en-7-yl]-2-oxoacetate Chemical compound N=1C2(CCl)C(=O)N(C(=O)C(=O)OCC)C2SC=1C1=CC=CC=C1 HDCDLRXOWXHIHY-UHFFFAOYSA-N 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- DGVNWNYQSOYWKZ-UHFFFAOYSA-N methyl dihydrogen phosphite Chemical class COP(O)O DGVNWNYQSOYWKZ-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- UEPYRPCZFZWSLO-UHFFFAOYSA-N n-(1-methyl-2-oxo-4-sulfanylazetidin-3-yl)acetamide Chemical compound CN1C(S)C(NC(C)=O)C1=O UEPYRPCZFZWSLO-UHFFFAOYSA-N 0.000 description 1
- PWYMVBQSMVRFDU-UHFFFAOYSA-N n-[1-(4-methylphenyl)sulfonyl-2-oxo-4-sulfanylazetidin-3-yl]-2-phenylethanethioamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C(=O)C(NC(=S)CC=2C=CC=CC=2)C1S PWYMVBQSMVRFDU-UHFFFAOYSA-N 0.000 description 1
- TUHZKMXFKFHDPC-UHFFFAOYSA-N n-[2-oxo-4-sulfanyl-1-(2,2,2-trifluoroacetyl)azetidin-3-yl]benzamide Chemical compound O=C1N(C(=O)C(F)(F)F)C(S)C1NC(=O)C1=CC=CC=C1 TUHZKMXFKFHDPC-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- VYGSFTVYZHNGBU-UHFFFAOYSA-N trichloromethanesulfonic acid Chemical compound OS(=O)(=O)C(Cl)(Cl)Cl VYGSFTVYZHNGBU-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Description
(54) Způsob přípravy 2-oxo-3-acylamino-4-merkaptoazetidinů(54) A process for the preparation of 2-oxo-3-acylamino-4-mercaptoazetidines
Předložený vynález se týká způsobu přípravy 2-oxo-3-acylamino-4-merkaptoazetidinů obecného vzorce IThe present invention relates to a process for the preparation of 2-oxo-3-acylamino-4-mercaptoazetidines of the formula I
R1GONH SHR 1 GONH SH
kde R1 je benzyl nebo fenoxymethyl, pwherein R 1 is benzyl or phenoxymethyl, p
R je atom vodíku nebo skupiny vzorcůR is a hydrogen atom or a group of formulas
YY
-CHR3-COX nebo -C=<Í!-CH2-Hal'-CHR 3 -COX or -C = CH 2 -Hal '
COX kde R^ je isopropenyl nebo atom vodíku,COX where R 6 is isopropenyl or a hydrogen atom,
X .je 1-morfolinyl, hydroxyl, methyl, dimethylaminoskupina, 1-piperidinyl, Hal' je atom halogenu,X 1 is 1-morpholinyl, hydroxyl, methyl, dimethylamino, 1-piperidinyl, Hal 'is halogen,
X je p-nitrobenzyl, 2,2,2-trichlorethoxyskupina, p-nitrobenzyloxyskupina, benzyloxyskupina, terc.butoxyskupina, difenylmethoxyskupina, který se vyznačuje tím, že se thiazolinový kruh sloučenin obecného vzorce II R1 (II) N\ 2 O RZ X is p-nitrobenzyl, 2,2,2-trichloroethoxy group, a p-nitrobenzyloxy, benzyloxy, t-butoxy, difenylmethoxyskupina, characterized in that the thiazoline ring of compounds of formula II R 1 (II) N \ Z 2 OR
2 kde R a R mají výše uvedený význam, štěpí kyselinou, jako je například kyselina chloristá, kyselina chlorovodíková, kyselina sírová, kyselina fosforečná, kyselina oxelová, kyselina p-toluensulfonová, kyselina trifluoroctová a chlorid rtutnatýv přítomnosti alespoň t molekulárního ekvivalentu vody v rozpouštědle, jako je například dichlormethan, chloroform, aceton, benzen, ethylacetát, dioxan, tetrahydrofuran, methanol nebo ethanol při teplotě -10 °C až 70 °C.Wherein R and R are as defined above, cleaving with an acid such as perchloric acid, hydrochloric acid, sulfuric acid, phosphoric acid, oxelic acid, p-toluenesulfonic acid, trifluoroacetic acid and mercuric chloride in the presence of at least 1 molar equivalent of water in the solvent, such as dichloromethane, chloroform, acetone, benzene, ethyl acetate, dioxane, tetrahydrofuran, methanol or ethanol at -10 ° C to 70 ° C.
Sloučeniny obecného vzorce II se mohou pojmenovat jako 7-oxo-4-thia-2,6-diazabicyklo[3,2,0j -hept-2-eny.The compounds of formula II may be named as 7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-enes.
Výchozí materiál se může jřipravit například z odpovídajících esterů penicilín-1-oxidu působením methylfosfitů nebo reakcí jeho produktů běžně známými metodami.The starting material can be prepared, for example, from the corresponding penicillin-1-oxide esters by treatment with methylphosphites or by reaction of its products by conventional methods.
Rozklad azetidinothiazolinové sloučeniny vodnou kyselinou je nová obecná reakce pro získání 4-merkapto-3-karboxy-acylamino-2-oxoazetidinových derivátů podle reakčního schémaDecomposition of the azetidinothiazoline compound with aqueous acid is a novel general reaction for obtaining 4-mercapto-3-carboxy-acylamino-2-oxoazetidine derivatives according to the reaction scheme
2 ' kde R a R mají výše uvedený význam.Wherein R and R are as defined above.
Může se provádět také reakcí thiazolinoazetidinu vzorce II s kyselinou a vodou. Reakce vody je nutná pro štěpení thiazolinového kruhu za vzniku 4-merkapto- a 3-acylaminoazetldinového kruhu. Výhodná kyselina zahrnuje minerální kyseliny (například halogenovodíkové kyseliny, kyselinu sírovou, kyselinu dusičnou, kyselinu fosforečnou, kyselinu chloristou, kyselinu chlornou), sulfonovou kyselinu (například alkansulfonovou kyselinu, arylsulfonovou kyselinu, arylalkylsulfonovou kyselinu, zejména alfa-halogenalkensulfonovou kyselinu, alfa-halogenkarboxylovou kyselinu, polykarboxylovou kyselinu, s výhodou kyseliny s disociační konstantou alespoň 0,01.It can also be carried out by reacting the thiazolinoazetidine of formula II with acid and water. The reaction of water is necessary to cleave the thiazoline ring to form a 4-mercapto- and 3-acylamino-azetidine ring. Preferred acids include mineral acids (e.g., hydrohalic acids, sulfuric acid, nitric acid, phosphoric acid, perchloric acid, hypochlorous acid), sulfonic acid (e.g. alkanesulfonic acid, arylsulfonic acid, arylalkylsulfonic acid, especially alpha-haloalkenesulfonic acid, alpha-halocarboxylic acid polycarboxylic acid, preferably acids with a dissociation constant of at least 0.01.
Fřesněji jsou tyto kyseliny silnými kyselinami, jako je například chloristá kyselina, trifluoroctová kyselina, trichloroctová kyselina, dichloroctová kyselina, trifluormethansulfonová kyselina, trichlormethansulfonová kyselina, kyselina fluoroboritá, kyselina chlorovodíková, kyselina fluorovodíková, kyselina bromovodíková, kyselina dusičná, kyselina fosforečná, kyselina benzensulfonová, kyselina toluensulfonová, kyselina brombenzensulfonová, kyselina methansulfonová, kyselina ethansulfonová apod.More specifically, these acids are strong acids such as perchloric acid, trifluoroacetic acid, trichloroacetic acid, dichloroacetic acid, trifluoromethanesulfonic acid, trichloromethanesulfonic acid, fluoroboric acid, hydrochloric acid, hydrofluoric acid, hydrobromic acid, nitric acid, phosphoric acid, benzenesulfonic acid toluenesulfonic acid, bromobenzenesulfonic acid, methanesulfonic acid, ethanesulfonic acid and the like.
Reakce se může provádět v rozpouštědlech, která zahrnují uhlovodíky (pentan, hexan, benzen, toluen apod.), halogenované uhlovodíky (methylenchlorid, chloroform, chlorid uhličitý, dichlorbenzen, atd.), estery (ethylacetát, butylacetát, methylbenzoát, apod.), ketony (aceton, cyklohexanon, benzofenon apod.), ethery (diethylether, ethylenglykol, dimethylether, tetrahydrofuran, tetrahydropyran, dioxan, morfolin, anisol apod.), alkoholy (methanol, ethanol, ethylenglykol, benzylalkohol apod.), karboxylové kyseliny (kyselina octová kyselina propionová apod.), báze (butylamin, triethylamin, pyridin, pikolin apod.), amidy (dimethylformamid, dimethylacetamid, hexamethylfosforamid apod.), nitrily (acetonitril, benzonitril apod.), nitrované uhlovodíky, sulfoxidy (dimethylsulfoxid apod.), voda a jejich směsi.The reaction may be carried out in solvents which include hydrocarbons (pentane, hexane, benzene, toluene, etc.), halogenated hydrocarbons (methylene chloride, chloroform, carbon tetrachloride, dichlorobenzene, etc.), esters (ethyl acetate, butyl acetate, methyl benzoate, etc.), ketones (acetone, cyclohexanone, benzophenone, etc.), ethers (diethyl ether, ethylene glycol, dimethyl ether, tetrahydrofuran, tetrahydropyran, dioxane, morpholine, anisole, etc.), alcohols (methanol, ethanol, ethylene glycol, benzyl alcohol, etc.), carboxylic acids (acetic acid) propionic acid and the like), bases (butylamine, triethylamine, pyridine, picoline, etc.), amides (dimethylformamide, dimethylacetamide, hexamethylphosphoramide etc.), nitriles (acetonitrile, benzonitrile, etc.), nitrated hydrocarbons, sulfoxides (dimethylsulfoxide etc.), water and mixtures thereof.
Výhodnějšími rozpouštědly jsou polární rozpouštědla schopná rozpouštět vodu a kyselinu (například ethery, ketony, alkoholy, amidy, sulfoxid, voda), rozpouštědla schopná rozpouštět výchozí materiál II (například halogenované uhlovodíky, estery, ethery, ketony) a jejich směsi.More preferred solvents are polar solvents capable of dissolving water and acid (e.g. ethers, ketones, alcohols, amides, sulfoxide, water), solvents capable of dissolving the starting material II (e.g. halogenated hydrocarbons, esters, ethers, ketones) and mixtures thereof.
Jestliže se používá silná kyselina, mohou probíhat vedlejší reakce, například rozklad azetidinonového kruhu. Výtěžek se může zlepšit výběrem reakčních podmínek, například koncentrací, teplotou, reakční dobou apod. Obecně reakce probíhá při teplotě místnosti rychle, někdy během 10 minut až 1 hodiny a získá se požadovaná sloučenina ve vysokém výtěžku.If a strong acid is used, side reactions such as decomposition of the azetidinone ring can take place. The yield can be improved by selecting reaction conditions, such as concentration, temperature, reaction time, and the like. Generally, the reaction proceeds rapidly at room temperature, sometimes within 10 minutes to 1 hour, to give the desired compound in high yield.
Produkty'jsou nestabilní vůči alkaliím a oxidaci. Proto se reakce a zpracování provádějí bez vystavování reakční směsi těmto podmínkám.The products are unstable to alkalis and oxidation. Therefore, the reactions and work-ups are carried out without subjecting the reaction mixture to these conditions.
Některé výchozí sloučeniny se připravují následujícími postupy:Some starting compounds are prepared by the following procedures:
Příprava IPreparation
K roztoku p-nitrobenzyl alfa- [3-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,0] hept -2-en-6-ylj-alfa-( I-hydroxyethyliden)acetát (504 mg) v tetrahydrofuranu (8 ml) se přikape za chlazení ledem methansulfonylchlorid (0,13 ml) a triethylamin (0,23 ml). Po třech hodinách se směs odpaří a zbyde odparek, který se rozpustí v methylenchloridu, promyje se vodou, vysuší .síranem hořečnatým a odpaří. Čištěním zbytku chromatografii na silikagelu obsahujícím 10 % vody (15 g) za použití směsi benzenu a ethylacetátu (5:1) se získá p-nitrobenzyl-alfa-|3-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,0]hept-2-en-6-yl] -alfa -(1-methansulfonyloxyethyliden)acetát (353 mg). Bezbarvá pěna.To a solution of p-nitrobenzyl alpha- [3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6-yl] -α- (1-hydroxyethylidene) acetate (504 mg) in tetrahydrofuran (8 mL) was added dropwise with ice-cooling methanesulfonyl chloride (0.13 mL) and triethylamine (0.23 mL). After three hours, the mixture was evaporated to leave a residue which was dissolved in methylene chloride, washed with water, dried over magnesium sulphate and evaporated. Purification of the residue by chromatography on silica gel containing 10% water (15 g) using benzene / ethyl acetate (5: 1) afforded p-nitrobenzyl-alpha-β-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3,2,0] hept-2-en-6-yl] - alpha - (1-methanesulfonyloxyethylidene) acetate (353 mg). Colorless foam.
CHCI ” 1I WANT ”1
Produkt neobsahuje geometrický isomer v poloze alfa. IČ: vmax3 780» 1 730 cmThe product does not contain a geometric isomer in alpha position. IR: max3 780 »1730 cm
NMR: δ CDC13 2.60, s, 3H, 3.18, s, 3H, 4,58 + 4,88, ABq, (14Hz), 2H, 5.24, s, 2H, 5.92 + + 6.08, ABq, (5HZ), 2H, 6.73 - 8,20, m, 9H.NMR: δ CDCl 3 2.60, s, 3H, 3.18, s, 3H, 4.58 + 4.88, ABq, (14Hz), 2H, 5.24, s, 2H, 5.92 + + 6.08, ABq, (5HZ), 2H, 6.73-8.20, m, 9H.
Příprava 2Preparation 2
K roztoku p-nitrobenzyl alfa-[3-fenoxymethyl-7-Žco-4-thia-2,6-diazabicyklo [3,2, oj hept -2-en-6-ylJ-alfa-(1-hydroxyethyliden)acetátu (940 mg) v dimethylformamidu obsahujícím 10 % tetrahydrofuranu (5 ml) se přidá toluen-p-sulfonylchlorid (456 mg). Po ochlazení na -70 °C se roztok smísí s triethylaminem (0,3 ml). Reakční směs se nechá ohřát pomalu na teplotu místnosti, nalije se do vody, a extrahuje se ethylacetátem. Extrakt se promyje vodou, vysuší a odpaří. Získaný odparek se chromatografuje na silikagelu s 10 % vody použitím benzenu a 5 % ethylacetátu. Získá se p-nitrobenzyl alfa-[3-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2, oj hept-2-en-6-yí] -alfa-( 1-toluen-p-sulfonyloxyethyliden)acetát (644 mg). IČ:.v ^X3 1 785', 1 735 cm1. NMR: δ CDCI3 2.45, s, 3H, 4.75 + 4.20, ABq, (14Hz), 2H, 5.15, s, 2H, 5,77, s, 2H, 8,30 - 6.60, m, 13H.To a solution of p-nitrobenzyl alpha- [3-phenoxymethyl-7-ω-4-thia-2,6-diazabicyclo [3.2.1] hept-2-en-6-yl] -α- (1-hydroxyethylidene) acetate ( 940 mg) in dimethylformamide containing 10% tetrahydrofuran (5 mL) was added toluene-p-sulfonyl chloride (456 mg). After cooling to -70 ° C, the solution was treated with triethylamine (0.3 mL). The reaction mixture was allowed to warm slowly to room temperature, poured into water, and extracted with ethyl acetate. The extract was washed with water, dried and evaporated. The residue obtained is chromatographed on silica gel with 10% water using benzene and 5% ethyl acetate. There was thus obtained p-nitrobenzyl .alpha .- [3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.1] hept-2-en-6-yl] -. (sulfonyloxyethylidene) acetate (644 mg). IR: .in X ^ 3 1785 ', 1735 cm 1st NMR: δ CDCl 3 2.45, s, 3H, 4.75 + 4.20, ABq, (14Hz), 2H, 5.15, s, 2H, 5.77, s, 2H, 8.30-6.60, m, 13H.
Příprava 3Preparation 3
K roztoku p-nitrobenzyl alfa-[3-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2, Oj hept -2-en-6-yl]-alfa-(1-methansulfonylethyliden)acetátu (298 mg) v benzenu (3 ml) se přidá mor folin (0,095 ml) při 7 až 10 °C. Po 130 minutách se reakční směs filtruje a filtrát se nalije do ledové vody a extrahuje se methylenchloridem. Extrakt se promyje vodou, vysuší síranem hořečnatým a odpařením se získá p-nitrobenzyl alfa- [3-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,oj hept-2-en-6-ylJ -alfa-( 1-morfolinoethyliden)acetát (284 mg). Pěna. Výtěžek 97,1%.To a solution of p-nitrobenzyl alpha- [3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6-yl] -alpha- (1-methanesulfonylethylidene) acetate (298 mg) in benzene (3 mL) was added folin plague (0.095 mL) at 7-10 ° C. After 130 minutes, the reaction mixture was filtered and the filtrate was poured into ice water and extracted with methylene chloride. The extract was washed with water, dried (MgSO4) and evaporated to give p-nitrobenzyl .alpha .- [3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.1] hept-2-en-6-yl]. .alpha .- (1-morpholinoethylidene) acetate (284 mg). Foam. Yield 97.1%.
Produkt je směsí (asi 1:1) geometrických isomerů substituentu v poloze alfa.The product is a mixture (about 1: 1) of the geometric isomers of the substituent at the alpha position.
IČ:v 1 768, 1 685, 1 612, 1 603 om-1. NMR: 8 °DC13 1.90, s, IH, 2,42, s, 1H,IR: v 1,768, 1,685, 1,612, 1,623 om -1 . NMR: 8 ° DC1 3.90, s, 1H, 2.42, s, 1H,
3.17 - 3.43, m, 4H, 3.52 - 3.83, m, 4H, 4.87, s, 2H, 5.21, s, 2H, 5.58 - 6.00, m, 2H,3.17 - 3.43, m, 4H, 3.52 - 3.83, m, 4H, 4.87, s, 2H, 5.21, s, 2H, 5.58-6.00, m, 2H,
6.80 - 8.22, m, 9H.6.80-8.22, m, 9H.
Příprava 4Preparation 4
K roztoku 2,2,2-trichlorethyl-alfa- [j-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo- [3,2,Olhept-2-en-6-yl]-alfa-(1-methansulfonyloxyethyliden)acetátu (1,52 g) v benzenu (30 ml) se při teplotě pod 10 °C přidá morfolin (0,48 ml). Po jednohodinovém míchání se směs promyje vodou, vysuší a odpaří. Čištěním získaného zbytku chromatografií na silikagelu se získá 2,2,2-trichlorethyl alfa- [3-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo£3,2,0] hept-2-en-6-ylJ-alfa-(1-morfolinoethyliden)acetát (0,76 g). Výtěžek 50 %.To a solution of 2,2,2-trichloroethyl-alpha- [β-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.1] hept-2-en-6-yl] -alpha- ( 1-Methanesulfonyloxyethylidene) acetate (1.52 g) in benzene (30 mL) was added at below 10 ° C with morpholine (0.48 mL). After stirring for 1 hour, the mixture was washed with water, dried and evaporated. Purification of the residue by silica gel chromatography affords 2,2,2-trichloroethyl alpha- [3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6- yl-.alpha .- (1-morpholinoethylidene) acetate (0.76 g). Yield = 50%.
Produkt je směsí isomerů substituentu v poloze alfa.The product is a mixture of isomers of the substituent at the alpha position.
NMR:8 CDC13 1.88 + 2.42, s, 3H, 3.1 - 3.9, m, 8H, 4,73, ABq, (12Hz), 2H, 4.95, s,NMR: δ CDCl 3 1.88 + 2.42, s, 3H, 3.1-3.9, m, 8H, 4.73, ABq, (12Hz), 2H, 4.95, s,
2H, 5.7 - 6.2, m, 2H, 6.8 - 7-5, m, 5H.2H, 5.7-6.2, m, 2H, 6.8-7-5, m, 5H.
Příprava 5Preparation 5
K míchanému roztoku p-nitrobenzyl alfa-[3-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo- t3,2,0jhept-2-en-6-yl|-alfa-(1-hydroxyethyliden)acetátu (500 mg) v tetrahydrofuranu (20 mililitrů) se za chlazení ledem přikape methylchlorformiát (200 mg) a triethylamin (216 mg). Po jedné hodině se reakční směs naleje do ledové vody a extrahuje se ethylacetátem. Extrakt se promyje vodou, vysuší a odpařením se získá p-nitrobenzyl alfa-[3-fenoxymethy1 -7-oxo-4-thia-2,6-diazabicyklo [3,2,0] hept-2-en-6-ylj -alfa-( 1-methoxykarbonyloxyethylideň)acetát (546 mg). Pěna. Výtěžek: 97 %·To a stirred solution of p-nitrobenzyl alpha- [3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3,2.0] hept-2-en-6-yl] -alpha- (1-hydroxyethylidene) acetate (500 mg) in tetrahydrofuran (20 mL) was added dropwise methyl chloroformate (200 mg) and triethylamine (216 mg) under ice-cooling. After one hour, the reaction mixture was poured into ice water and extracted with ethyl acetate. The extract was washed with water, dried and evaporated to give p-nitrobenzyl alpha- [3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6-yl] - alpha - (1-methoxycarbonyloxyethylidene) acetate (546 mg). Foam. Yield: 97% ·
Produkt je směsí (asi 2:1) geometrických isomerů v poloze alfa.The product is a mixture (about 2: 1) of the geometric isomers in the alpha position.
lCvmax13 1 783· ’ 732> 1 642i 1 6,2> 1 600 cm”1· 10111:8 CDCl3 ’·95» s’ ,H> 2,47 ’ s’ LCV max 13 1783 · '732> 1642 i 1 6.2> 1600 cm' 1 · 10111: CDCl3 8 '· 95 »s' H> 2.47 's'
2H, 3.68, s. 1H, 3.80, s, 2H, 4.54 + 4.86, ABq, (14Hz), 4/3H, 4.86, s, 2/3H, 5.25, s, 3H,2H, 3.68, s, 1H, 3.80, s, 2H, 4.54 + 4.86, ABq, (14Hz), 4 / 3H, 4.86, s, 2 / 3H, 5.25, s, 3H,
5.73 - 6.03, m, 2H, 6.70 - 8.16, m, 9H.5.73-6.03, m, 2H, 6.70-8.16, m, 9H.
Příprava 6Preparation 6
K roztoku 2,2,2-trichlorethyl alfa-[3-benzyl-7-oxo-2,6-diaza-4-thiabicyklo[3,2,0|hept-2-en-6-yl]-alfa-(1-hydroxyethyliden)acetátu (450 mg) v methylenchloridu (7 ml) se přidá při teplotě -25 °C methansulfonylchlorid (0,093 ml) a triethylamin (0,48 ml) a směs se udržuje při této teplotě 40 minut. K vzniklému roztoku 2,2,2-trichlorethyl álfa-[3-benzyl-7-oxo-4-thia-2,6-diazabicyklo [3,2, o] hept-2-en-6-yl] -alfa-(1 -methansulfonyloxyethyliden)acetátu se přikape morfolin (0,112 ml) a směs se míchá 1,3 hodiny. Reakční směs se promyje vodou, vysuší a odpařením získaný zbytek se čistí chromatografií na silikagelu s 10 Sé vody a získá se 2,2,2-trichlorethyl alfa-[3-benzyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,0] hept-2-en-6-yl] -alfa-( 1-morfolinoethyliden)acetát (205 mg).To a solution of 2,2,2-trichloroethyl alpha- [3-benzyl-7-oxo-2,6-diaza-4-thiabicyclo [3.2.0] hept-2-en-6-yl] -alpha- ( 1-hydroxyethylidene) acetate (450 mg) in methylene chloride (7 mL) was added at -25 ° C methanesulfonyl chloride (0.093 mL) and triethylamine (0.48 mL) and the mixture was held at this temperature for 40 minutes. To the resulting solution of 2,2,2-trichloroethyl .alpha .- [3-benzyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6-yl] -alpha. (1-methanesulfonyloxyethylidene) acetate was added dropwise with morpholine (0.112 mL) and the mixture was stirred for 1.3 hours. The reaction mixture was washed with water, dried and the residue was purified by chromatography on silica gel with 10% water to give 2,2,2-trichloroethyl alpha- [3-benzyl-7-oxo-4-thia-2,6-diazabicyclo [3,2,0] hept-2-en-6-yl] -alpha- (1-morpholinoethylidene) acetate (205 mg).
Produkt je směsí (asi 1:1,6) geometrických isomerů v poloze alfa.The product is a mixture (about 1: 1.6) of the geometric isomers in the alpha position.
NMR:8CDC13 1.67, s, +2.35, s, [3H] , 2.83 - 4,00, m, 8H, 2.31, s, 2H, 4.45 + 4.88, q, (12Hz), 4.47 + 4.83, q, (12Hz), [2H] , 5.60 - 6.12, m, 2H, 7.22, s, +7.23, s, [5H] .NMR 8CDC1 3 1.67, s, +2.35, p, [3H], 2.83 to 4.00, m, 8H, 2.31, s, 2H, 4.45 + 4.88, q, (12Hz), 4.47 + 4.83, q, ( 12Hz), [2H], 5.60-6.12, m, 2H, 7.22, s, +7.23, s, [5H].
Příprava 7Preparation 7
K míchanému roztoku p-nitrobenzyl alfa-[3-benzyl-7-oxo-4-thia-2,6-diazabicyklo[3,2,0]hept-2-en-6-yl|-alfa-(1-hydroxyethyliden)acetátu (680 mg) v tetrahydrofuranu (15 ml) se přidá za chlazení ledem methansulfonylchlorid (0,18 ml) a triethylamin (0,31 ml) a reakční směs se míchá jednu hodinu. Vyloučené krystaly se odfiltrují a filtrát se odpaří, čištěním odparku (800 mg) chromatografií na silikagelu s 10 % vody (25 g) se získá z frakcí eluovaných benzenem a ethylacetátem (2:1) p-nitrobenzyl alfa-[3-benzyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,0]hept-2-en-6-yl]-alfa-(1-methansulfonyloxyethyliden)acetát (609 mg). Výtěžek 76,6 %.To a stirred solution of p-nitrobenzyl alpha- [3-benzyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6-yl] -alpha- (1-hydroxyethylidene) Methylsulfonyl chloride (0.18 mL) and triethylamine (0.31 mL) were added under ice-cooling with ice-cooling (680 mg) in tetrahydrofuran (15 mL) and the reaction mixture was stirred for one hour. The precipitated crystals were filtered off and the filtrate was evaporated, purification of the residue (800 mg) by chromatography on silica gel with 10% water (25 g) gave p-nitrobenzyl alpha- [3-benzyl-7] eluted fractions eluted with benzene and ethyl acetate (2: 1). oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6-yl] -alpha- (1-methanesulfonyloxyethylidene) acetate (609 mg). Yield 76.6%.
Produkt neobsahuje geometrický isomer v poloze alfa.The product does not contain a geometric isomer in alpha position.
lC:vmaxl3 1 784> 1 728’ 1 700’ 1 614 cm 1· ™R;8GDC13 2.58, s, 3H, 3.00, s, 3H, 3.79, s, 2H, 5.18, s, 2H, 5.85 + 6.00, ABq, (5Hz), 2H, 7.22, s, +8.23, m, 9H. lC: v max l3 1,784 > 1,728 ' 1,700 ' 1,614 cm 1 · ™ R; 8GDC1 3 2.58, s, 3H, 3.00, s, 3H, 3.79, s, 2H, 5.18, s, 2H, 5.85 + 6.00, ABq, (5Hz), 2H, 7.22, s, + 8.23, m, 9H.
Příprava8Preparation8
K roztoku p-nitrobenzyl alfa- [3-benzyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,θ] hept-2-en-6-yl] -alfa-(1-methansulfonyloxyethyliden)acetátu (609 mg) v methylenchloridu (3 ml) se při -15 °C přidá morfolin (0,2 ml) a směs se míchá 50 minut při této teplotě. Reakční směs se nalije do ledové vody a extrahuje se methylenchloridem. Extrakt se promyje vodou, vysuší a odpaří. Čištěním získané pěny (569 mg) se chromatografují na silikagelu (25 g) získá z frakcí eluovaných směsí benzenu a ethylacetátu (2:1) p-nitrobenzyl alfa- [j-benzyl-7-oxo-4-thia-2,6-diazabicyklo |j, 2,0] hept-2-en-6-yl] -alfa-( 1-morfolinoethyliden)acetát (452 mg). Výtěžek 75,5 %. Pěna.To a solution of p-nitrobenzyl alpha- [3-benzyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6-yl] -alpha- (1-methanesulfonyloxyethylidene) of acetate (609 mg) in methylene chloride (3 mL) at -15 ° C was added morpholine (0.2 mL) and the mixture was stirred at this temperature for 50 min. The reaction mixture was poured into ice water and extracted with methylene chloride. The extract was washed with water, dried and evaporated. Purification of the resulting foam (569 mg) was chromatographed on silica gel (25 g) to obtain p-nitrobenzyl alpha- [β-benzyl-7-oxo-4-thia-2,6-] from the fractions eluted with 2: 1 benzene / ethyl acetate. diazabicyclo [1,2.0] hept-2-en-6-yl] -alpha- (1-morpholinoethylidene) acetate (452 mg). Yield 75.5%. Foam.
Produkt neobsahuje geometrické isomery v poloze alfa.The product does not contain geometric isomers in alpha position.
IČ:v CHCl-j , ?78) , 695> , 615 ^-1, CDC1^ 2>37j s> 3H> 3>θθ _ 3>73> 8Hj IR: in CHCl3 ,? 78) , 695 ?, 615 ? -1, CDCl ? 2? 37 ? S ? 3H? 3?? 3? 73? 8H?
3.86, s, 2H, 5.20, s, 3H, 5.73 + 5.88, ABq, (5Hz), 2H, 7.15 - 8.28, m, 9H.3.86, s, 2H, 5.20, s, 3H, 5.73 + 5.88, ABq, (5Hz), 2H, 7.15-8.28, m, 9H.
Tyto produkty jsou také nové a odpovídají následujícímu vzorci IIIThese products are also new and correspond to the following formula III
R1 R 1
I ^c\ (III)I ^ c \ (III)
N S —-N xc=ctNS ——N x c = ct
I coxI cox
Ύ' kde R1 má význam uvedený výše, ϊ' je uhlíkatá acyloxyskupina obsahující do 12 atomů uhlíku, disubstituovaná aminoskupina obsahující 2 až 20 atomů uhlíku nebo aromatická nebo alifatická sulfonylskupina obsahující 1 až 20 atomů uhlíku a X je hydroxyskupina nebo skupina chránící karboxylovou skupinu.Kde 'wherein R 1 is as defined above, ϊ' is a carbon acyloxy group containing up to 12 carbon atoms, a disubstituted amino group having 2 to 20 carbon atoms or an aromatic or aliphatic sulfonyl group having 1 to 20 carbon atoms and X is a hydroxy or carboxyl protecting group.
Předložený vynález je blíže objasněn v následujících příkladech.The present invention is illustrated by the following examples.
Příklad 1Example 1
K roztoku 3-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,0]hept-2-enu (200 mg) ve směsi methylenchloridu (6 ml) a acetonu (8 ml) se přidá 30% vodný roztok kyseliny chloristé (1,0 ml) a směs se míchá 40 minut při teplotě místnosti. Po zředění přebytkem vody se reakční směs extrahuje methylenchloridem. Extrakt se promyje vodou, vysuší síranem sodným a zahustí. Jako odparek se získá bílý krystalický 4beta-merkapto-3beta-fenoxyacetamido-2-oxoazetidin, t. t. 137 až 138 °C.[a]j3 +38,0 + 3,0° [c = 0,261, CHC13 a C^OH (4:1)].To a solution of 3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-ene (200 mg) in a mixture of methylene chloride (6 mL) and acetone (8 mL) was added A 30% aqueous solution of perchloric acid (1.0 mL) was added and the mixture was stirred at room temperature for 40 minutes. After dilution with excess water, the reaction mixture was extracted with methylene chloride. The extract was washed with water, dried over sodium sulfate and concentrated. As a residue, a white crystalline 4beta-mercapto-3p-phenoxyacetamido-2-oxo-azetidine, mp 137-138 ° C. [A] J 3 + 3,0 +38,0 ° [c = 0.261, CHC1 3, and C-OH (4: 1)].
IČ:v 3 290, 3 200, 2 562, 1 757, 1 658, 1 549 cm-’. NMR:6 ^-DMSO 3>,?> brs, 1H, 4,58, s, 2H, 5,00, brs, 1H, 5,32, dd, (9; 5Hz), 1H, 6,80 - 7,43, m, 6H.IR: 3290, 3200, 2562, 1757, 1658, 1549 cm - '. NMR: 6 ^ -DMSO 3>?> Br s, 1H, 4.58, s, 2H, 5.00, br s, 1H, 5.32, dd, (9, 5 Hz) 1H, 6.80 - 7 , 43, m, 6H.
Příklad 2Example 2
K roztoku esteru R3 alfa- [3-substituované(R1)-7-oxo-4-thia-2,6-diazabicyklo [3,2,Oj hept-2-en-6-yl]-alfa-substituované (R2)-octové kyseliny (5) v rozpouštědle se přidá kyselina a směs se míchá při uvedené teplotě uvedenou dobu. Reakční směs se zředí vodou a extrahuje se methylenchloridem. Extrakt se promyje vodou, vysuší síranem sodným a získá se požadovaný ester (R3) alfa-[4-merkapto-3-substituovaná amino (Rl-C0NH)-2-oxoazetidin-l-yl]-alfa-substituované (R2) octové kyseliny.To a solution of the R 3 alpha- [3-substituted (R 1 ) -7-oxo-4-thia-2,6-diazabicyclo [3.2.1] hept-2-en-6-yl] -alpha-substituted ester ( R 2 ) -acetic acid (5) in the solvent is added acid and the mixture is stirred at the indicated temperature for the indicated time. The reaction mixture was diluted with water and extracted with methylene chloride. The extract was washed with water, dried over sodium sulfate to give the desired (R 3 ) alpha- [4-mercapto-3-substituted amino (R 1 -CONH) -2-oxoazetidin-1-yl] -alpha-substituted (R 2 ) ester acetic acid.
Tabulka I udává reakční podmínky a tabulka II udává fyzikální konstanty produktu.Table I gives the reaction conditions and Table II gives the physical constants of the product.
V tabulce I je uveden hmotnostní výtěžek surových produktů. Produkty jsou podle analýzy chromatografií na tenké vrstvě a podle NMR-spektra téměř čisté. Některé z nich byly čištěny krystalizaci.Table I shows the crude product yield by weight. The products are almost pure according to thin layer chromatography and NMR spectra. Some of them were purified by crystallization.
ι φι φ
oO
Ο γΜΟ γΜ
WW
Ρ ,Μ '>> Φ ί> *3 b£) aΡ, Μ '>> Φ ί> * 3 b £) a
α >οα> ο
Λ} βΛ} β
ΦΦ
CX φCX φ
ΗΗ
Ό >ΦΌ> Φ
ΡΡ
ΧΟΧΟ
ΟΟ
CXCX
ΝΝ
Ο ϊ?Ο ϊ?
ο οο ο
ΓΜ CM rM ' Ο σΊ ΓΜ ® ® Ο Ο οR CM rM Ο σΊ Ί ® ® Ο Ο ο
οο
ΓΜ CM rM ο m CM® ® Ο ΟΓΜ CM rM ο m CM® ® Ο Ο
Ο οΟ ο
CM CM rM ' Ο ΟΊCM CM rM 'Ο ΟΊ
ΓΜ ® ® Ο ΟΓΜ ® ® Ο Ο
ΟΟ
ΟΟ
ΓΜ ΓΜ γΜΓΜ ΓΜ γΜ
Ο m ΓΜ® ® Ο ο οΟ m ΓΜ ® ® Ο ο ο
ο οο ο
Μ-Ο ® σ' νο® Ο ΟΜ-Ο ® σ 'νο® Ο Ο
ΟΟ
CMO γΜ ο σΊCMO γΜ ο σΊ
CM® ® ο ο οCM® ® ο ο ο
οο
ΓΜ ΓΜ Η m. Ο σΊΓΜ ΓΜ Η m
ΓΜ ® ® Ο ΟΓΜ ® ® Ο Ο
Ο οΟ ο
ΓΜ tCMΓΜ tCM
ΓΜΓΜ
οί γμ ®οί γμ ®
Μ Ο 0=0Ο 0 = 0
IAND
ββ
X» βX »β
ΕΜ φΕΜ φ
ϋϋ
Μ βΜ β
φ . ® Ο ιφ. ® Ο ι
χυ ρ # >» φ νοχυ ρ #> φ νο
X)X)
Λ) © © a Φ ο « Ό©) © © and Φ ο «Ό
ΙΑ 'Φ ©ΙΑ 'Φ ©
ΡΡ
Ο ι-ΙΟ ι-Ι
Ο.Ο.
φφ
Ε-» ρΕ- »ρ
•ϋ md• ϋ md
Ρ χη οΡ χη ο
λ (4 (§λ (4 (
Μ WΜ W
ΟΊΟΊΑΟΠ σ\οο · γ—, • · © Η —’Φ y LZJ©ΑΟΠ σ \ οο · γ—, • © L — 'Φ y LZJ
Ό*-04 θ’—'Ολ — σ* * ·©04 * -04 θ ’- 'Ολ - σ * * · ©
ΟΟ
ΟΟ
ΟΟ
04 ι-904 ι-9
Ο θ'» <Μ« &Θ θ '<<& «&
a ο 53 θ’— É9 οand ο 53 θ’— É9 ο
ββ
Ρ οΡ ο
ΉΉ
Β ©Β ©
ρρ
Ο γΗΟ γΗ
ΙΑ 00 — Tt * tΙΑ 04 c\i σ> -ΦνΟ00Α 00 - Tt * tΙΑ 04 c \ i σ> -ΦνΟ
ΙΑ ·Φ ου σ\ ΦνΟ aΙΑ · Φ ου σ \ ΦνΟ
οο
0) &90) & 9
© β© β
χυχυ
ο.ο.
a οand ο
§ δ§ δ
¢9¢ 9
Ο βΟ β
Ό cm 2C ίβ Ο Ο -«Ο I onsi naΌ cm 2C ίβ Ο Ο - Ο I onsi na
BOKO 0-0 0-0BOKO 0-0 0-0
II IIII II
Χ3 •3 φ « « χυ•3 • 3 φ «« χυ
© β© β
Μ &Μ &
«ι *55
ΜΜ
3>3>
Ε-» >ο 3 © ο β Η ·Η ω βΕ- »> ο 3 © ο β Η · Η ω β
V reakcích č. 3 a 6 se požadované sloučeniny získají v nízkém výtěžku spolu s velkým množstvím výchozího materiálu a vedlejších produktů.In reactions Nos. 3 and 6, the desired compounds are obtained in low yield along with a large amount of starting material and by-products.
Příklad 3Example 3
K roztoku p-nitrobenzyl alfa- [3-fenoxymethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,o]hept -2-en-6-yl]-alfa-isopropenylacetátu (200 mg) v tetrahydrofuranu (5 ml) se přidá kyselina štavelová (200 mg) a voda (0,5 ml) a směs se míchá tři hodiny při teplotě místnosti. Chroinatogram yeakční směsi vykazuje přítomnost p-nitrobenzyl alfa-[4-merkapto-3-fenoxyacetamido-2-oxo-azet.idin-1-yl]-alfa-isopropenylacetátu a výchozího materiálu.To a solution of p-nitrobenzyl alpha- [3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6-yl] -alpha-isopropenyl acetate (200 mg) in tetrahydrofuran (5 ml) oxalic acid (200 mg) and water (0.5 ml) were added and the mixture was stirred at room temperature for three hours. The chromatogram of the reaction mixture shows the presence of p-nitrobenzyl alpha- [4-mercapto-3-phenoxyacetamido-2-oxo-azetidin-1-yl] -alpha-isopropenylacetate and the starting material.
Příklad 4Example 4
Postupem podle příkladu 2 se připraví následující sloučeniny:Following the procedure of Example 2, the following compounds were prepared:
(1) 4~merkapto-3-thienylacetamido-2-oxo-1-acetylazetldin z 6-acetyl-3-thienylmethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,0]hept-2-enu, (2) 4-merkapto-3-benzamido-2-oxo-1-trifluoracetylazetidin z 6-trifluoracetyl-3-fenyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,0] hept-2-enu, (3) 4-merkapto-3-acetamido-2-oxo-1-methylazetidin z 3,6-dimethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2, Ó] hept-2-enu, (4) 4-merkapto-3-(alfa-fenyl-alfa-chloracetamido)-2-oxo-1-karbethoxykarbonylazetidin z 6-karbethoxykarbonyl-3-fenylchlormethyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,o]hept-2-enu, (5) alfa-[4-merkapto-3-formamido-2-oxoazetidin-1-yl]-alfa-isopropyliden octová kyselina z alfa-[7-oxo-4-thia-2,6-diazabicyklo [3,2,0] hept-2-en-6-yl]-alfa-isopropyliden octové kyseliny a (6) 4-merkapto-3-benzylthiokarbonylamino-2-oxo-1-p-toluensulfonylazetidin z 3-benzyl-thio-6-p-toluensulfonyl-7-oxo-4-thia-2,6-diazabicyklo [3,2,0]hept-2-enu.(1) 4-mercapto-3-thienylacetamido-2-oxo-1-acetylazetidine from 6-acetyl-3-thienylmethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2 (2) 4-mercapto-3-benzamido-2-oxo-1-trifluoroacetylazetidine from 6-trifluoroacetyl-3-phenyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] (3) 4-mercapto-3-acetamido-2-oxo-1-methylazetidine from 3,6-dimethyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-ene (4) 4-mercapto-3- (alpha-phenyl-alpha-chloroacetamido) -2-oxo-1-carbethoxycarbonylazetidine from 6-carbethoxycarbonyl-3-phenylchloromethyl-7-oxo-4-thia- 2,6-diazabicyclo [3.2.0] hept-2-ene, (S) alpha - [4-mercapto-3-formamido-2-oxoazetidin-1-yl] - alpha -isopropylidene acetic acid from alpha - [ 7-Oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-en-6-yl] -α-isopropylidene acetic acid and (6) 4-mercapto-3-benzylthiocarbonylamino-2- oxo-1-p-toluenesulfonylazetidine from 3-benzyl-thio-6-p-toluenesulfonyl-7-oxo-4-thia-2,6-diazabicyclo [3.2.0] hept-2-ene.
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50033808A JPS5817460B2 (en) | 1975-03-20 | 1975-03-20 | Thiazoline Kanno Kaikanhouhou |
CS101776A CS207653B2 (en) | 1975-02-21 | 1976-02-17 | Method of preparation of thehalogenated 2-oxoazetidines |
Publications (1)
Publication Number | Publication Date |
---|---|
CS207656B2 true CS207656B2 (en) | 1981-08-31 |
Family
ID=25745366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS78971A CS207656B2 (en) | 1975-03-20 | 1978-02-15 | Method of preparation of 2-oxo-3-acylamino-4-mercap-toazetidins |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS207656B2 (en) |
-
1978
- 1978-02-15 CS CS78971A patent/CS207656B2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL141782B1 (en) | Method of obtaining epimers of 7 beta-malonamido-7 alpha-methoxy-3-tetazolylthiomethyl-1-destia-1-oxa-3-cephemocarboxylic-4 esters | |
JPWO2004007471A1 (en) | N-phenyl- (2R, 5S) dimethylpiperazine derivative | |
DK161330B (en) | OXAZOLINOAZETIDE INGREDIENTS USED AS INTERMEDIATES IN THE PREPARATION OF 1-OXADETHIACEPHALOSPORINES AND PROCEDURES FOR THE PREPARATION OF THE OXAZOLINOAZETIDE INGREDIENTS | |
EP1767538B1 (en) | Process for producing 1-oxacephalosporin-7alpha-methoxy-3-chloromethyl derivative | |
DE2806457C2 (en) | ||
CS207656B2 (en) | Method of preparation of 2-oxo-3-acylamino-4-mercap-toazetidins | |
IL33057A (en) | 2-acyloxycephalosporin compounds having antibiotic activity,intermediates useful in their preparation and process for preparing said compounds and intermediates | |
US4093800A (en) | Process for preparing cepham compounds | |
EP0052299A1 (en) | 2-Oxoazetidine derivatives and production thereof | |
RU2043988C1 (en) | 4-oxoazetidine-2-sulfonic acids or their salts as intermediate products for synthesis of beta-lactam antibiotics and a method of their synthesis | |
WO1991009037A1 (en) | Process for producing 3-substituted thio-3-cephem compound | |
SU833162A3 (en) | Method of preparing 1-oxadethiacephalosporins | |
PL111962B1 (en) | Process for preparing novel derivatives of azetidinone | |
US3825531A (en) | Process for producing penicillin derivatives | |
FI68239C (en) | KRISTALLINA 3-HYDROXICEPHALOSPORINSOLVAT SOM AER MELLANPRODUKTER VID FRAMSTAELLNING AV 3-HYDROXICEFALOSPORINER ANVAENDBARA SOM MELLANPRODUKTER VID FRAMSTAELLNING AV CEFALOSPORINER OCHFOERFARANDO F | |
PL114624B1 (en) | Process for preparing novel cephem derivatives | |
JPS61246187A (en) | 1-oxadethiacepham compound | |
Aoki et al. | New route to 3-(substituted) methyl 1-oxa-and (1-thia) cephems from 3-exomethylene intermediates via sulfenyl chloride adducts | |
KR800001527B1 (en) | Preparing process for cepham intermediate | |
SU1308198A3 (en) | Method of producing 7-amino-3-substituted methyl-delta-3-cephem-4-carbonic acid or its acid-additive salts | |
US3960851A (en) | Preparation of desacetoxy-cephalosporin sulfoxides from penicillin sulfoxides | |
IL44360A (en) | 7-acylamido-3-hydroxy-3-cephem-4-carboxylic acid 3-sulfonates | |
PL117503B1 (en) | Process for preparing novel 1-dethia-1-oxacephame derivativesama | |
JP2980992B2 (en) | Method for producing 6-halogeno-2-oxapregna-4,6-dien-3-one compound | |
US7057045B2 (en) | Process for obtaining 17β-(substituted)-3-oxo-Δ1,2-4-azasteroids and intermediates |